Non-Alcoholic Steatohepatitis

Research Workshop to be held at the
National Institutes of Health
Lister Hill Auditorium
December 10-11, 1998
Bethesda, MD


The aim of this meeting is to synthesize current understanding of the condition known as non-alcoholic steatohepatitis (NASH) and to outline specific areas of future research in better defining its etiology, natural history and treatment.

December 10, 1998 (Thursday)

Session 1: NASH - The Clinical Syndrome: Jay Hoofnagle and Jackie Maher

8:30 a.m.
8:40 alm.
9:00 a.m.
9:20 a.m.
9:40 a.m.
10:00 a.m.
10:20 a.m.
Welcome
What is NASH? Overview
Clinical Features of NASH
Natural History of NASH
Obesity and Liver Disease
Discussion
Break
Jay Hoofnagle, NIH
Bruce Bacon, St. Louis University
Arun Sanyal, MCV, Richmond, VA
Arthur McCullough, Metro. Cleveland
Jay Everhart, NIH

Session 2: NASH - Clinical Correlations: Oliver James and Tom Boyer

10:50 a.m.
11:10 a.m.
11:30 a.m.
11:50 a.m.
12.10 p.m.
12:30 p.m.
NASH in Children
Diabetes and Liver Disease
Insulin Resistance and NASH
NASH and Liver Transplantation
Discussion
Lunch
Joel Lavine, UCSD, CA
Ian Wanless, Toronto, Canada
David Herion, NIH
Michael Sorrell, Omaha, NE

Session 3: Pathology of NASH - Moderators: Jay Lefkowitch and Randy Lee

1:30 p.m.
1:50 p.m.
2:10 p.m.

2:30 p.m.
2:50 p.m.
3:10 p.m.
Pathology of NASH
Grading and Staging
Roundtable Discussion

Iron and NASH
Non-invasive diagnosis
Break
Zack Goodman, AFIP
David Kleiner, NIH
Goodman, Brunt, Kleiner, Lefkowitch,
Lee, Ludwig and Wanless
Herb Bonkovsky, Univ. of Mass.
Tom Boyer, Emory

Session 4: Pathogenesis of Steatosis and NASH: Anna Mae Diehl and Simeon Taylor

3:30 p.m.
3:50 p.m.
4:10 p.m.
4:30 p.m.
4:50 p.m.
5:20 p.m.
6:00 p.m.
7:30 p.m.
Pathogensis of NASH: Overview
Hepatic Fab Metabolism
CYP450 and NASH
Cox-2, Inflammation and the Liver
Discussion
Posters
Adjourn
Dinner Banquet
Nathan Bass, UCSF
Robert Wolfe, Galveston, TX
Geoffrey Farrel, Sydney, Australia
Andrew Dannenberg, Cornell

December 11, 1998 (Friday)

Session 5: Pathophysiology of Steatosis and Liver Injury: Bruce Bacon and
Geoffrey Farrell

8:30 a.m.
8:50 a.m.
9:10 a..m.
9:30 a.m.
9:50 a.m.
10.20 a.m.
Alcohol injury and NASH
Cytokines and NASH
Mitochondrial injury and NASH
Animal Models of NASH
Discussion
Break
Jackie Maher, UCSF, San Francisco
Craig McClain, Univ. Kentucky
Dominique Pessayre, Paris
Anna Mae Diehl, Johns Hopkins

Session 6: Treatment of NASH - Moderators: Arun Sanyal and Joel Lavine

10:50 a.m.
11:10 a.m.
11:30 a.m.
12:00 p.m.
Weight loss and NASH
Anti-oxidants and NASH
Discussion
Synthesis and Conclusions
Oliver James, Newcastle on Tyne, UK
Keith Lindor, Mayo Clinic

Jay Hoofnagle, NIH

For further information or to register for the meeting, contact
Ms. Tracy Morgan, Conference Manager
(301) 493-9674 or
E-mail: Morgan@ccc76.com

Registration deadline: Monday, November 30, 1998 (space is limited)
Registration fee: $75